Uncategorized
Visus Therapeutics to Present at the Baird 2023 Global Healthcare Conference
SEATTLE & IRVINE, Calif.--(BUSINESS WIRE)--Visus Therapeutics Inc., a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapies for indications in the front and back of the eye, today announced that Ben Bergo, co-founder and chief executive officer, will present at the Baird 2023 Global Healthcare Conference on September 12th, 2023, at the InterContinental New York Barclay hotel. The presentation is scheduled for 8:30 AM Eastern Time on Tuesday, Septembe